Developing innovative solutions to improve therapies and the well-being of patients with movement disorders
Big Idea
inSignals Neurotech is a spin-off from the University of Porto, focused on developing innovative solutions to improve therapies and the well-being of patients with movement disorders. Founded by INESC TEC, Prof. João Paulo Cunha and Frontier IP Group, the company is developing iHandU, a disruptive solution to quantify muscle rigidity. The goal is to reduce variability in symptom assessment, support doctors in clinical decisions and therapy personalisation and empowering patients to manage their disease. Our mission is to drive technological advancement in neurology and make a significant impact on patients’ quality of life.
Activity Highlights
- i3S-Hovione Capital Innovation Prize – First Place
- EIT Health Start-ups Meet Pharma – Second Place
- Recognition as EIT Health “Rising Star company”
- The Spinoff Prize – Nature Research Award in partnership with Merck – honorable mention as “Ones to Watch 2020”
- Award in the category “Accelerator” from the program Startup Generation do RESOLVE-HEALTH by i3S
- Finalist from the program “X-linker: Healthtech for Pharma” by 5-HT Digital Hub- Chemistry & Health
- Award “Winner of the Best Paper Award” with a scientific article published in the IEEE Melecon Magazine 2022
Team
Sara Reis – Diretora-Geral; João Paulo Cunha – Scientific Chief Advisor; Patricia Lopes – Product Owner.
Portugal Ventures’ Investment Manager
